These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15359827)

  • 1. [Genetic variability and clinical significance of hypervariable region of hepatitis C virus].
    Hino K; Korenaga M; Okuda M; Okita K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):385-90. PubMed ID: 15359827
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular virology of hepatitis C.
    Major ME; Feinstone SM
    Hepatology; 1997 Jun; 25(6):1527-38. PubMed ID: 9185778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sequence diversity and variability in the putative envelope proteins including hypervariable regions of hepatitis C virus].
    Nakazawa T; Hijikata M; Kato N; Shimotohno K
    Nihon Rinsho; 1993 Feb; 51(2):318-22. PubMed ID: 8385235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Hepatology; 1993 Dec; 18(6):1293-9. PubMed ID: 8244252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
    Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
    J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
    Shimizu YK; Igarashi H; Kiyohara T; Cabezon T; Farci P; Purcell RH; Yoshikura H
    Virology; 1996 Sep; 223(2):409-12. PubMed ID: 8806581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
    Shindo M; Okuno T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):376-80. PubMed ID: 15359825
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequence variations of the hypervariable region of hepatitis C virus and their clinical significance.
    Zhang S; Wang W; Zhou K; Liu H
    Chin Med J (Engl); 2000 Dec; 113(12):1075-9. PubMed ID: 11776139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural and functional characterization of the hypervariable region in the HCV genome].
    Tanaka M; Yokosuka O; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):43-7. PubMed ID: 15359761
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
    Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
    Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of hypervariable region gene of hepatitis C virus between an individual infected persistently and an individual recovered from infection].
    Pan W; Wang H; Wang T
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):26-8. PubMed ID: 10366981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens.
    Takeda T; Tatsumi N; Nakayama Y; Yasuda T; Nishiguchi S; Seki S
    J Med Virol; 2005 Jan; 75(1):35-41. PubMed ID: 15543585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus genomic variability in untreated and immunosuppressed patients.
    Lawal Z; Petrik J; Wong VS; Alexander GJ; Allain JP
    Virology; 1997 Feb; 228(1):107-11. PubMed ID: 9024815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral escape from humoral immune system by mutations in hypervariable region of HCV envelope protein and mechanism of persistent viral infection].
    Kato N; Nakazawa T; Sekiya H; Mizutani T; Shimotohno K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):129-35. PubMed ID: 7563673
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective transmission of hepatitis C virus quasi species through a needlestick accident in acute resolving hepatitis.
    Liu CH; Chen BF; Chen SC; Lai MY; Kao JH; Chen DS
    Clin Infect Dis; 2006 May; 42(9):1254-9. PubMed ID: 16586384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis.
    Fan X; Di Bisceglie AM
    Am J Gastroenterol; 2002 Jun; 97(6):1489-95. PubMed ID: 12094871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amino acid substitution of hepatitis C virus for persistent infection].
    Yamaguchi K; Kohara M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):136-42. PubMed ID: 7563676
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent advance of research for hepatitis C virus].
    Shimotohno K; Hijikata M; Kato N
    Tanpakushitsu Kakusan Koso; 1991 Aug; 36(10):1679-91. PubMed ID: 1719583
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of near full-length hepatitis C virus quasispecies variants from a complex population.
    Zhou D; Fan X; Tan D; Xu Y; Tavis JE; Di Bisceglie AM
    J Virol Methods; 2007 May; 141(2):220-4. PubMed ID: 17208310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.